financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions
Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions
Jul 9, 2025
08:49 AM EDT, 07/09/2025 (MT Newswires) -- (Updates with the company statement from the third paragraph.) CVS Health's ( CVS ) Omnicare unit was ordered to pay $948.8 million in penalties and damages in a whistleblower lawsuit alleging it fraudulently billed the US government for invalid drug prescriptions, Reuters reported Tuesday, citing a court order. US District Judge Colleen McMahon...
Update: Market Chatter: UnitedHealth's Former Doctors Questioned by Prosecutors Regarding Medicare Billing Practices
Update: Market Chatter: UnitedHealth's Former Doctors Questioned by Prosecutors Regarding Medicare Billing Practices
Jul 9, 2025
08:48 AM EDT, 07/09/2025 (MT Newswires) -- (Updates with UnitedHealth's ( UNH ) response in the fourth and fifth paragraphs and latest stock moves in sixth paragraph.) UnitedHealth's ( UNH ) Medicare billing practices are being investigated by the US Justice Department's criminal healthcare-fraud unit, The Wall Street Journal reported Wednesday, citing people familiar with the matter. The investigation includes...
Revolution Medicines, Iambic Therapeutics Form AI-Powered Drug Discovery Partnership
Revolution Medicines, Iambic Therapeutics Form AI-Powered Drug Discovery Partnership
Jul 9, 2025
08:49 AM EDT, 07/09/2025 (MT Newswires) -- Revolution Medicines ( RVMD ) and Iambic Therapeutics said Wednesday they have entered a multi-year agreement to discover new drug candidates using AI-driven models. Under the agreement, Iambic will train customized versions of its AI models using proprietary structures and molecular libraries provided by Revolution Medicines ( RVMD ), the company said. Both...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved